In summary, to the best of our knowledge, this is the first study to report that EA pre-treatment downregulates calpain-2 expression, thereby inhibiting the phosphorylation of STAT3 and improving cardiac function during sepsis. This evidence concerns the gene STAT3 and Sepsis.